Wells Fargo
EOLS icon

Wells Fargo’s Evolus EOLS Stock Holding History

Wells Fargo’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-32,700
Closed -$4K – 6979
2020
Q4 		$4K Buy
+32,700
New +$123K ﹤0.01% 6179

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Wells Fargo's EOLS Position: Q2 2026 in Review

Wells Fargo increased its Evolus (EOLS) stake by 14% in Q2 2026, buying an estimated $60.5K and bringing the position to 84,748 shares worth $588K. The position accounts for ﹤0.01% of the portfolio, ranked #4504.

Wells Fargo first reported a position in EOLS in Q1 2018 and has held it in 34 quarters since. The position peaked at $717K in Q1 2019. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Wells Fargo held 84,748 shares of Evolus worth $588K as of Q2 2026.
  • Wells Fargo bought 10,251 Evolus shares in Q2 2026, an estimated $60.5K.
  • Evolus made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4504 holding.
  • Wells Fargo first reported a position in Evolus in Q1 2018 and has held it in 34 quarters since.
  • Wells Fargo's Evolus position peaked at $717K in Q1 2019.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.